Skip to main content

Etoposide

NDC 68001-683 · BluePoint Laboratories

Generic nameEtoposide
Dosage formINJECTION, SOLUTION, CONCENTRATE
RouteINTRAVENOUS
Active ingredient(s)ETOPOSIDE
Strength20 mg/mL
Pharmacologic classTopoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
Marketing categoryANDA

Packages

68001-683-27 — 1 VIAL, MULTI-DOSE in 1 CARTON (68001-683-27) / 50 mL in 1 VIAL, MULTI-DOSE

Billed under HCPCS

J9187 — Injection, etoposide, 1 mg Medicare Part B payment limit (ASP + 6%): $0.09

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0143-9376 — Etoposide, 0143-9510 — Etoposide, 0143-9511 — Etoposide, 0143-9512 — Etoposide, 0378-3266 — etoposide, 16729-114 — Etoposide, 63323-104 — ETOPOSIDE, 68001-265 — Etoposide, 68001-681 — Etoposide, 68001-682 — Etoposide, 69238-2811 — Etoposide, 71288-175 — Etoposide, 71288-176 — Etoposide, 71288-177 — Etoposide, 83270-451 — ETOPOSIDE, 83831-144 — etoposide, 83831-145 — etoposide

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources